In Vitro Diagnostic Reagents Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Technology, By Use, By End User, By Region and Competition, 2020-2030F

Description

The Global In Vitro Diagnostic (IVD) Reagents Market, valued at USD 78.75 Billion in 2024, is projected to experience a CAGR of 5.35% to reach USD 107.66 Billion by 2030. In vitro diagnostic (IVD) reagents are biochemical or biological substances essential for tests conducted outside the human body, enabling the detection, diagnosis, monitoring, and treatment of diseases by analyzing patient samples. The global IVD reagents market demonstrates robust growth, primarily supported by the increasing worldwide prevalence of chronic and infectious diseases, coupled with a rising demand for personalized medicine which necessitates highly specific diagnostic solutions. This consistent requirement for accurate and timely diagnostic information underpins the sustained expansion of the market.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 78.75 Billion
Market Size 2030	USD 107.66 Billion
CAGR 2025-2030	5.35%
Fastest Growing Segment	Immunoassay
Largest Market	North America

Key Market Drivers

The escalating global prevalence of chronic and infectious diseases is a primary driver for in vitro diagnostic reagents. Conditions such as cancer, diabetes, cardiovascular diseases, and emerging infectious pathogens necessitate continuous and extensive diagnostic testing for screening, accurate diagnosis, and disease management. This persistent need directly increases the consumption of IVD reagents across diverse diagnostic platforms. For example, the substantial global cancer burden underscores this demand.

Key Market Challenges

The extensive regulatory requirements significantly impede the growth of the Global In Vitro Diagnostic (IVD) Reagents Market. The complex certification processes and lengthy timelines restrict the timely introduction and availability of new diagnostic products. For example, according to a MedTech Europe survey in 2024, the choice of the EU as the first launch geography for IVD large manufacturers dropped by 40% due to regulatory burdens, indicating a diversion of innovation away from this critical market. This directly translates to fewer innovative reagents reaching patients and healthcare providers, thus limiting market expansion.

Key Market Trends

The shift towards decentralized and point-of-care (POC) testing is expanding diagnostic capabilities beyond traditional laboratory settings, bringing testing closer to patients and facilitating more immediate clinical decisions. This trend necessitates the development of robust, user-friendly reagent formulations compatible with smaller, often portable devices. Such decentralization is crucial for improving access to timely diagnostics, particularly in remote areas or emergency situations.

Key Market Players

Thermo Fisher Scientific Inc
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc
Agilent Technologies, Inc.
QIAGEN N.V.
Merck KGaA
Beckman Coulter, Inc
Hologic, Inc
Abcam Ltd
Bio-Techne Corp

Report Scope:

In this report, the Global In Vitro Diagnostic (IVD) Reagents Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

In Vitro Diagnostic (IVD) Reagents Market, By Type:

Antibodies
Purified Proteins and Peptides
Oligonucleotides
Others

In Vitro Diagnostic (IVD) Reagents Market, By Technology:

Immunoassay
Clinical Chemistry
Molecular Diagnostics
Microbiology
Hematology
Others

In Vitro Diagnostic (IVD) Reagents Market, By Use:

Clinical Use
Research Use
Others

In Vitro Diagnostic (IVD) Reagents Market, By End User:

IVD Manufacturers
Academic Institutes & Research Laboratories
Hospital Laboratories
Others

In Vitro Diagnostic (IVD) Reagents Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global In Vitro Diagnostic (IVD) Reagents Market.

Available Customizations:

Global In Vitro Diagnostic (IVD) Reagents Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global In Vitro Diagnostic (IVD) Reagents Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Type (Antibodies, Purified Proteins and Peptides, Oligonucleotides, Others)
- 5.2.2. By Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Others)
- 5.2.3. By Use (Clinical Use, Research Use, Others)
- 5.2.4. By End User (IVD Manufacturers, Academic Institutes & Research Laboratories, Hospital Laboratories, Others)
- 5.2.5. By Region
- 5.2.6. By Company (2024)
5.3. Market Map

6. North America In Vitro Diagnostic (IVD) Reagents Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Type
- 6.2.2. By Technology
- 6.2.3. By Use
- 6.2.4. By End User
- 6.2.5. By Country
6.3. North America: Country Analysis
- 6.3.1. United States In Vitro Diagnostic (IVD) Reagents Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Type
    - 6.3.1.2.2. By Technology
    - 6.3.1.2.3. By Use
    - 6.3.1.2.4. By End User
- 6.3.2. Canada In Vitro Diagnostic (IVD) Reagents Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Type
    - 6.3.2.2.2. By Technology
    - 6.3.2.2.3. By Use
    - 6.3.2.2.4. By End User
- 6.3.3. Mexico In Vitro Diagnostic (IVD) Reagents Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Type
    - 6.3.3.2.2. By Technology
    - 6.3.3.2.3. By Use
    - 6.3.3.2.4. By End User

7. Europe In Vitro Diagnostic (IVD) Reagents Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Type
- 7.2.2. By Technology
- 7.2.3. By Use
- 7.2.4. By End User
- 7.2.5. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany In Vitro Diagnostic (IVD) Reagents Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Type
    - 7.3.1.2.2. By Technology
    - 7.3.1.2.3. By Use
    - 7.3.1.2.4. By End User
- 7.3.2. France In Vitro Diagnostic (IVD) Reagents Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Type
    - 7.3.2.2.2. By Technology
    - 7.3.2.2.3. By Use
    - 7.3.2.2.4. By End User
- 7.3.3. United Kingdom In Vitro Diagnostic (IVD) Reagents Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Type
    - 7.3.3.2.2. By Technology
    - 7.3.3.2.3. By Use
    - 7.3.3.2.4. By End User
- 7.3.4. Italy In Vitro Diagnostic (IVD) Reagents Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Type
    - 7.3.4.2.2. By Technology
    - 7.3.4.2.3. By Use
    - 7.3.4.2.4. By End User
- 7.3.5. Spain In Vitro Diagnostic (IVD) Reagents Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Type
    - 7.3.5.2.2. By Technology
    - 7.3.5.2.3. By Use
    - 7.3.5.2.4. By End User

8. Asia Pacific In Vitro Diagnostic (IVD) Reagents Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Type
- 8.2.2. By Technology
- 8.2.3. By Use
- 8.2.4. By End User
- 8.2.5. By Country
8.3. Asia Pacific: Country Analysis
- 8.3.1. China In Vitro Diagnostic (IVD) Reagents Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Type
    - 8.3.1.2.2. By Technology
    - 8.3.1.2.3. By Use
    - 8.3.1.2.4. By End User
- 8.3.2. India In Vitro Diagnostic (IVD) Reagents Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Type
    - 8.3.2.2.2. By Technology
    - 8.3.2.2.3. By Use
    - 8.3.2.2.4. By End User
- 8.3.3. Japan In Vitro Diagnostic (IVD) Reagents Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Type
    - 8.3.3.2.2. By Technology
    - 8.3.3.2.3. By Use
    - 8.3.3.2.4. By End User
- 8.3.4. South Korea In Vitro Diagnostic (IVD) Reagents Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Type
    - 8.3.4.2.2. By Technology
    - 8.3.4.2.3. By Use
    - 8.3.4.2.4. By End User
- 8.3.5. Australia In Vitro Diagnostic (IVD) Reagents Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Type
    - 8.3.5.2.2. By Technology
    - 8.3.5.2.3. By Use
    - 8.3.5.2.4. By End User

9. Middle East & Africa In Vitro Diagnostic (IVD) Reagents Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Type
- 9.2.2. By Technology
- 9.2.3. By Use
- 9.2.4. By End User
- 9.2.5. By Country
9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia In Vitro Diagnostic (IVD) Reagents Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Type
    - 9.3.1.2.2. By Technology
    - 9.3.1.2.3. By Use
    - 9.3.1.2.4. By End User
- 9.3.2. UAE In Vitro Diagnostic (IVD) Reagents Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Type
    - 9.3.2.2.2. By Technology
    - 9.3.2.2.3. By Use
    - 9.3.2.2.4. By End User
- 9.3.3. South Africa In Vitro Diagnostic (IVD) Reagents Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Type
    - 9.3.3.2.2. By Technology
    - 9.3.3.2.3. By Use
    - 9.3.3.2.4. By End User

10. South America In Vitro Diagnostic (IVD) Reagents Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Type
- 10.2.2. By Technology
- 10.2.3. By Use
- 10.2.4. By End User
- 10.2.5. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil In Vitro Diagnostic (IVD) Reagents Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Type
    - 10.3.1.2.2. By Technology
    - 10.3.1.2.3. By Use
    - 10.3.1.2.4. By End User
- 10.3.2. Colombia In Vitro Diagnostic (IVD) Reagents Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Type
    - 10.3.2.2.2. By Technology
    - 10.3.2.2.3. By Use
    - 10.3.2.2.4. By End User
- 10.3.3. Argentina In Vitro Diagnostic (IVD) Reagents Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Type
    - 10.3.3.2.2. By Technology
    - 10.3.3.2.3. By Use
    - 10.3.3.2.4. By End User

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Global In Vitro Diagnostic (IVD) Reagents Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Thermo Fisher Scientific Inc
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
15.2. Becton, Dickinson and Company
15.3. Bio-Rad Laboratories, Inc
15.4. Agilent Technologies, Inc.
15.5. QIAGEN N.V.
15.6. Merck KGaA
15.7. Beckman Coulter, Inc
15.8. Hologic, Inc
15.9. Abcam Ltd
15.10. Bio-Techne Corp